ERS Genomics Limited and DefiniGEN Ltd announced a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents
The study of communities migrating from Southeast Asia could provide insight into some of the metabolic health issues affecting immigrants to the country